Capital Markets Day 2021 Presentation
Diaceutics PLC
("Diaceutics" or "the Group")
Capital Markets Day
Diaceutics PLC (AIM: DXRX), the diagnostic commercialisation company, hosted a virtual Capital Markets Day ("CMD") for investors and equity analysts on Wednesday 16th June 2021.
The event was hosted by Group CEO, Peter Keeling, and included a series of presentations, a demonstration of the DXRX SaaS platform, and views from an industry expert panel including:
Pharmaceutical Partner: a senior executive within one of the world’s top five pharmaceutical companies
Laboratory Partner: Professor Giancarlo Pruneri, Head of Pathology Fondazione IRCCS Istituto Nazionale Tumori, Milan
Key Opinion Leader: Dr Avi Kulkarni, SVP and R&D leader at Nasdaq listed technology firm Cognizant
In addition, a strategic update was heard from the Company, along with a live Q&A.
If you are interested in the contents or have any questions relating to the Diaceutics Capital Markets Day please contact [email protected]
Enquiries
Diaceutics PLC
Peter Keeling, Chief Executive Officer
Philip White, Chief Financial Officer
Stifel Nicolaus Europe Limited (Nominated Adviser and Broker)
Ben Maddison
Stewart Wallace
Nick Adams
+44 (0)20 7710 7600
Alma PR
Caroline Forde
Robyn Fisher
Kieran Breheny
Tel: +44 (0)20 3405 0205
[email protected]
About Diaceutics
At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome.
We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network ®
